Clinical and pharmaceutical success from discovery to regulatory approval: biomarkers, modeling and analytical technologies

Bioanalysis. 2017 Oct;9(19):1437-1440. doi: 10.4155/bio-2017-4978. Epub 2017 Oct 21.

Abstract

The 8th Annual Shanghai Symposium on Clinical and Pharmaceutical Solutions through Analysis (CPSA): Clinical and Pharmaceutical Success from Discovery to Regulatory Approval: Biomarkers, Modeling and Analytical Technologies (CPSA Shanghai 2017); Renaissance Shanghai Pudong Hotel, Shanghai, China, 12-14 April 2017 was held on 12-14 April 2017 in Shanghai, China. The meeting was featured with highly interactive events including diversified symposia, workshops, roundtable discussions, conference awards and poster sessions. There were over 220 participants with 61 oral presentations and 20 posters presented. In addition, the meeting included a preconference workshop with an inaugural session on the evaluation of quality and efficacy for generic drugs in China.

Keywords: DMPK; LC–MS bioanalysis; biomarker; biomolecule; drug development; generic drug; quality and efficacy evaluation.

MeSH terms

  • Biomarkers / analysis
  • Chemistry Techniques, Analytical
  • Drug Approval / legislation & jurisprudence*
  • Drug Discovery / methods*
  • Inventions
  • Models, Biological*
  • Pharmaceutical Preparations / metabolism
  • Social Control, Formal*
  • Tissue Distribution

Substances

  • Biomarkers
  • Pharmaceutical Preparations